Table 1 Patient characteristics.

From: C-reactive protein is superior to fecal biomarkers for evaluating colon-wide active inflammation in ulcerative colitis

Characteristics

N = 78

Age (year), mean (range) ± SD

47.3 (18‒77) ± 16.7

Male/female, n (%)

47 / 31 (60.3 / 39.7)

Disease duration (year), mean (range) ± SD

10.9 (0.3‒38) ± 10.3

Disease extent, n (%)

Extensive colitis

43 (55.1)

Left-sided colitis

28 (35.9)

Proctitis

7 (9.0)

CAI (Lichtiger’s score) mean (range) ± SD

2.21 (0‒15) ± 2.87

M-MES mean (range) ± SD

0.87 (0‒3) ± 0.86

S-MES mean (range) ± SD

1.86 (0‒8) ± 2.13

UCEIS mean (range) ± SD

1.91 (0‒7) ± 1.94

UCCIS mean (range) ± SD

16.14 (0‒81.2) ± 19.05

FC (µg/g) mean (range) ± SD

3448.3 (8.9‒49,300) ± 7945.5

FIT (ng/mL) mean (range) ± SD

2651.6 (30‒45,900) ± 7195.5

CRP (mg/dL) mean (range) ± SD

0.39 (0.02‒7.23) ± 1.10

Medication at study, n (%)

Oral 5‒ASA

53 (67.9)

Suppository 5‒ASA

9 (11.5)

Systemic steroids

9 (11.5)

Immunomodulators

24 (30.8)

Biologics

25 (32.1)

  1. CAI Clinical activity index, S-MES Sum of Mayo endoscopic subscore, M-MES Maximum Mayo endoscopic subscore, UCEIS Ulcerative colitis endoscopic index of severity, UCCIS Ulcerative colitis colonoscopic index of severity, FC Fecal calprotectin, FIT Fecal immunochemical occult blood test, CRP C-reactive protein, 5-ASA 5-aminosalicylic acid.
Back to article page